SBA
EW icon

Seven Bridges Advisors’s Edwards Lifesciences EW Stock Holding History

Seven Bridges Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,364
Closed -$427K – 34
2017
Q4 		$427K Sell
11,364
-414
-4% -$15.2K 0.35% 70
2017
Q3 		$429K Buy
11,778
+1,836
+18% +$70K 0.36% 75
2017
Q2 		$392K Sell
9,942
-3,000
-23% -$110K 0.35% 72
2017
Q1 		$406K Sell
12,942
-870
-6% -$27.2K 0.39% 72
2016
Q4 		$431K Buy
13,812
+3,204
+30% +$104K 0.44% 64
2016
Q3 		$426K Buy
10,608
+102
+1% +$3.84K 0.38% 67
2016
Q2 		$349K Sell
10,506
-285
-3% -$9.75K 0.3% 81
2016
Q1 		$317K Buy
10,791
+7,767
+257% +$214K 0.25% 86
2015
Q4 		$80K Buy
+3,024
New +$78.5K 0.08% 140

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Seven Bridges Advisors's EW Position: Q1 2018 in Review

Seven Bridges Advisors sold out of Edwards Lifesciences (EW) in Q1 2018, closing a stake of 11,364 shares — an estimated $427K sold.

Seven Bridges Advisors first reported a position in EW in Q4 2015 and held it in 9 quarters. The position peaked at $431K in Q4 2016. 815 funds tracked by Wall St. Rank hold EW as of Q1 2018.

  • Seven Bridges Advisors reported no remaining Edwards Lifesciences position as of Q1 2018 after selling out during the quarter.
  • Seven Bridges Advisors sold 11,364 Edwards Lifesciences shares in Q1 2018, an estimated $427K.
  • Seven Bridges Advisors first reported a position in Edwards Lifesciences in Q4 2015 and held it in 9 quarters.
  • Seven Bridges Advisors's Edwards Lifesciences position peaked at $431K in Q4 2016.
  • 815 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2018.

Based on Seven Bridges Advisors's 13F filing for Q1 2018, filed 9 May 2018.